Drug intelligence / Profile preview

life's Omega

Development stage
Unknown
Lead developer
DSM-Firmenich
Administration
Oral
01

Overview

life's Omega is a proprietary, algae-based omega-3 dietary supplement ingredient produced from *Schizochytrium* sp. microalgae. It is a vegan-certified source of long-chain polyunsaturated fatty acids, containing primarily docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). It is used as the active omega-3 source in various dietary supplements and fortified foods. The mechanism is based on delivering high-purity plant-based DHA and EPA, which are incorporated into cell membranes throughout the body and exert physiological effects via modulation of inflammation, brain function, cardiovascular protection, and cell signaling pathways. The ingredient is produced under pharmaceutical-quality conditions, ensuring purity and oxidative stability and avoiding marine contamination and common allergens.

Brand names
life's Omega
Other names
life's Omega 60life's Omega O3020DSlife's Omega 1035DS
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)FFAR4 (Free fatty acid receptor 4)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on life's Omega.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on life's Omega.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call